New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?

被引:67
作者
Delbaere, A
Smits, G
Olatunbosun, O
Pierson, R
Vassart, G
Costagliola, S
机构
[1] Hop Erasme, Fertil Clin, B-1070 Brussels, Belgium
[2] Hop Erasme, Serv Genet Med, Brussels, Belgium
[3] Free Univ Brussels, Fac Med, IRIBHM, Brussels, Belgium
[4] Univ Saskatchewan, Coll Med, Reprod Biol Res Unit, Saskatoon, SK S7N 0W0, Canada
[5] Univ Saskatchewan, Coll Med, Dept Obstet Gynecol & Reprod Sci, Saskatoon, SK S7N 0W0, Canada
基金
加拿大健康研究院;
关键词
FSH receptor; OHSS; physiopathology;
D O I
10.1093/humrep/deh124
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
The recent identification of mutations in the FSH receptor gene, which display an increased sensitivity to hCG and are responsible for the development of spontaneous ovarian hyperstimulation syndrome (OHSS), provides for the first time the molecular basis for the physiopathology of spontaneous OHSS. Based on these recent findings, this paper underlines the differences between spontaneous and iatrogenic OHSS and proposes a model to account for the different chronology between the two forms of the syndrome. In the iatrogenic form, the follicular recruitement and enlargement occur during ovarian stimulation with exogenous FSH, while in the spontaneous form, the follicular recruitment occurs later through the stimulation of the FSH receptor by pregnancy-derived hCG. In both forms, massive luteinization of enlarged stimulated ovaries ensues, inducing the release of vasoactive mediators, leading to the development of the symptoms of OHSS.
引用
收藏
页码:486 / 489
页数:4
相关论文
共 30 条
[2]
Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures [J].
Aboulghar, MA ;
Mansour, RT .
HUMAN REPRODUCTION UPDATE, 2003, 9 (03) :275-289
[3]
Abramov Y, 1996, HUM REPROD, V11, P1381
[4]
Hyperreactio luteinalis despite the absence of a corpus luteum and suppressed serum follicle stimulating concentrations in a triplet pregnancy [J].
Check, JH ;
Choe, JK ;
Nazari, A .
HUMAN REPRODUCTION, 2000, 15 (05) :1043-1045
[5]
Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome [J].
Delbaere, A ;
Bergmann, PJM ;
GervyDecoster, C ;
Camus, M ;
deMaertelaer, V ;
Englert, Y .
HUMAN REPRODUCTION, 1997, 12 (02) :236-240
[6]
Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: Role of early pregnancy and ovarian gonadotropin stimulation [J].
Delbaere, A ;
Bergmann, PJM ;
GervyDecoster, C ;
DeschodtLanckman, M ;
deMaertelaer, V ;
Staroukine, M ;
Camus, M ;
Englert, Y .
FERTILITY AND STERILITY, 1997, 67 (06) :1038-1045
[7]
DELBAERE A, 1994, FERTIL STERIL, V62, P731
[8]
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review [J].
Delvigne, A ;
Rozenberg, S .
HUMAN REPRODUCTION UPDATE, 2002, 8 (06) :559-577
[9]
Increased concentrations of renin, aldosterone and Ca125 in a case of spontaneous, recurrent, familial, severe ovarian hyperstimulation syndrome [J].
Di Carlo, C ;
Bruno, PA ;
Cirillo, D ;
Morgera, R ;
Pellicano, M ;
Nappi, C .
HUMAN REPRODUCTION, 1997, 12 (10) :2115-2117
[10]
PREGNANCY-ASSOCIATED OVARIAN REFRACTORINESS TO GONADOTROPIN - MYTH [J].
DIZEREGA, G ;
HODGEN, GD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1979, 134 (07) :819-822